BioAtla Q3 profit misses expectations, while revenue is in line with expectations. – BioAtla Inc. (NASDAQ: )’s third-quarter report missed analyst estimates with earnings at the same level as forecast numbers. According to reports on Tuesday.

BioAtla’s earnings per share (EPS) was $-0.80 on revenue of $0.00. Analyst Comments Compiled by Expectations for the upcoming forecast were previously seen at $-0.77 per share based on earnings of $0.00.

Apart from BioAtla, there are other companies too. Markets report this month’s earnings in the healthcare sector of the NASDAQ Stock Exchange

Eli Lilly previously estimated Q3 earnings at $0.1 per share on revenue of $9.5B, and $-0.2 on revenue of $8.97B.

Meanwhile, UnitedHealth’s most recently reported performance beat analyst forecasts. Q3 earnings were $6.56 per share on revenue of $92.4B, beating analyst estimates for 2020. expects earnings per share to be around $6.33 based on revenue of $91.42B.

Follow the latest developments in company profits with the Earnings Calendar

Leave a Reply

Your email address will not be published. Required fields are marked *